Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP648866.RAAeW8sjD67XtvsWsplI5reTRbxZ9abl4LdBakfoWu5zo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP648866.RAAeW8sjD67XtvsWsplI5reTRbxZ9abl4LdBakfoWu5zo130_assertion type Assertion NP648866.RAAeW8sjD67XtvsWsplI5reTRbxZ9abl4LdBakfoWu5zo130_head.
- NP648866.RAAeW8sjD67XtvsWsplI5reTRbxZ9abl4LdBakfoWu5zo130_assertion wasGeneratedBy ECO_0000203 NP648866.RAAeW8sjD67XtvsWsplI5reTRbxZ9abl4LdBakfoWu5zo130_provenance.
- NP648866.RAAeW8sjD67XtvsWsplI5reTRbxZ9abl4LdBakfoWu5zo130_assertion wasDerivedFrom befree-20140225 NP648866.RAAeW8sjD67XtvsWsplI5reTRbxZ9abl4LdBakfoWu5zo130_provenance.
- NP648866.RAAeW8sjD67XtvsWsplI5reTRbxZ9abl4LdBakfoWu5zo130_assertion SIO_000772 20482316 NP648866.RAAeW8sjD67XtvsWsplI5reTRbxZ9abl4LdBakfoWu5zo130_provenance.
- NP648866.RAAeW8sjD67XtvsWsplI5reTRbxZ9abl4LdBakfoWu5zo130_assertion evidence source_evidence_literature NP648866.RAAeW8sjD67XtvsWsplI5reTRbxZ9abl4LdBakfoWu5zo130_provenance.
- NP648866.RAAeW8sjD67XtvsWsplI5reTRbxZ9abl4LdBakfoWu5zo130_assertion description "[These results indicate that combination of cathepsin E and doxorubicin is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant prostate cancer PPC-1 cells, thus indicating therapeutic potential for clinical use.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP648866.RAAeW8sjD67XtvsWsplI5reTRbxZ9abl4LdBakfoWu5zo130_provenance.